Skip to main content
. 2021 Aug;9(15):1229. doi: 10.21037/atm-21-1883

Figure 5.

Figure 5

Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. PARP inhibitor drugs are shown with a dark background. CT, conventional therapy; PARPi, poly (ADP-ribose) polymerase inhibitor; AI, angiogenesis inhibitor.